The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia

NCT04263454 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: Endotoxin, Escherichia Coli
PROCEDURE: Magnetic Resonance Spectroscopy

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]